SCHEMBL3635535

SCHEMBL3635535

CCN(C(=S)OC(N)=O)c1ccc(Oc2cccc(NC(=O)c3cccc(C(C)(C)C#N)c3)c2)cn1

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.46
KDR P35968 5/20 0.46
CYP2C9 P11712 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3640217 0.83 BRAF (0.54) BRAFKDRCYP2C9
SCHEMBL2857455 0.80 BRAF (0.68) BRAFCYP2C9
SCHEMBL3681542 0.78 KDR (0.48) BRAFKDR
SCHEMBL4287982 0.76 BRAF (0.57) BRAFKDRCYP2C9
SCHEMBL3638529 0.76 BRAF (0.57) BRAFKDRCYP2C9
SCHEMBL2190254 0.75 BRAF (0.57) BRAFKDRCYP2C9
SCHEMBL3643117 0.73 BRAF (0.57) BRAFCYP2C9
SCHEMBL2851320 0.73 BRAF (0.60) BRAFKDRCYP2C9
SCHEMBL2853720 0.72 BRAF (0.54) BRAFCYP2C9
SCHEMBL3643371 0.71 CDK8 (0.55) BRAFKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2162445-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2010-03-17 EP disclosed
WO-2008150015-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-11 WO disclosed